Empowered Funds’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.92M Buy
168,055
+93,424
+125% +$2.01M 0.03% 749
2025
Q4
$1.49M Buy
+74,631
New +$1.46M 0.03% 569
2025
Q2
Sell
-95,228
Closed -$1.73M 1798
2025
Q1
$1.73M Sell
95,228
-5,631
-6% -$101K 0.02% 815
2024
Q4
$1.75M Buy
100,859
+4,895
+5% +$94K 0.03% 789
2024
Q3
$1.85M Sell
95,964
-173,122
-64% -$3.19M 0.03% 701
2024
Q2
$4.41M Buy
269,086
+19,260
+8% +$299K 0.08% 360
2024
Q1
$3.81M Buy
249,826
+18,890
+8% +$297K 0.07% 391
2023
Q4
$3.7M Buy
230,936
+20,821
+10% +$291K 0.09% 308
2023
Q3
$2.73M Buy
210,115
+17,222
+9% +$224K 0.08% 350
2023
Q2
$2.46M Buy
+192,893
New +$2.41M 0.09% 329

Other funds holding INVA

Empowered Funds's INVA Position: Q1 2026 in Review

Empowered Funds increased its Innoviva (INVA) stake by 125% in Q1 2026, buying an estimated $2.01M and bringing the position to 168,055 shares worth $3.92M. The position accounts for 0.03% of the portfolio, ranked #749.

Empowered Funds first reported a position in INVA in Q2 2023 and has held it in 10 quarters since. The position peaked at $4.41M in Q2 2024. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Empowered Funds held 168,055 shares of Innoviva worth $3.92M as of Q1 2026.
  • Empowered Funds bought 93,424 Innoviva shares in Q1 2026, an estimated $2.01M.
  • Innoviva made up 0.03% of Empowered Funds's portfolio in Q1 2026, its #749 holding.
  • Empowered Funds first reported a position in Innoviva in Q2 2023 and has held it in 10 quarters since.
  • Empowered Funds's Innoviva position peaked at $4.41M in Q2 2024.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.